Search
for
Sort by
Research 30 of 1000+
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- JAK Inhibitors for Treatment of Alopecia Areata
- JAK inhibitors and alopecia areata
- JAK-inhibitors in dermatology: current evidence and future applications
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- Emerging drugs for alopecia areata: JAK inhibitors
- Under Development JAK Inhibitors for Dermatologic Diseases
- JAK Inhibitors in the Treatment of Lichen Planopilaris
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib—A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata
- JAK Inhibitors: A New Weapon in the Skin Care Providers' Arsenal.
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study